Shalini Saxena

Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors

Ganesh Samala, Parthiban Brindha Devi, Shalini Saxena et al. · Bioorganic & Medicinal Chemistry · 2016 · 66 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Structure-Guided Design of Novel Thiazolidine Inhibitors of <i>O</i>-Acetyl Serine Sulfhydrylase from Mycobacterium tuberculosis

Ömer Poyraz, Variam Ullas Jeankumar, Shalini Saxena et al. · Journal of Medicinal Chemistry · 2013 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design and synthesis of novel quinoline–aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors

Brahmam Medapi, Janupally Renuka, Shalini Saxena et al. · Bioorganic & Medicinal Chemistry · 2015 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

Discovery of novel inhibitors of <i>Mycobacterium tuberculosis</i> MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations

Shalini Saxena, Maaged Abdullah, Dharmarajan Sriram et al. · Journal of Biomolecular Structure and Dynamics · 2017 · 54 citations

Pharmacy, Medicinal Chemistry, Molecular Biology +17

Homology modeling, docking and structure-based virtual screening for new inhibitor identification of <i>Klebsiella pneumoniae</i> heptosyltransferase-III

Saroj Kumar Panda, Shalini Saxena, Lalitha Guruprasad · Journal of Biomolecular Structure and Dynamics · 2019 · 41 citations

Life Sciences, Biochemistry, Molecular Biology +17